Annual D&A
$836.00 K
+$494.00 K+144.44%
December 31, 2023
Summary
- As of February 7, 2025, ALXO annual depreciation & amortization is $836.00 thousand, with the most recent change of +$494.00 thousand (+144.44%) on December 31, 2023.
- During the last 3 years, ALXO annual D&A has risen by +$634.00 thousand (+313.86%).
- ALXO annual D&A is now at all-time high.
Performance
ALXO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$224.00 K
+$4000.00+1.82%
September 30, 2024
Summary
- As of February 7, 2025, ALXO quarterly depreciation & amortization is $224.00 thousand, with the most recent change of +$4000.00 (+1.82%) on September 30, 2024.
- Over the past year, ALXO quarterly D&A has increased by +$15.00 thousand (+7.18%).
- ALXO quarterly D&A is now at all-time high.
Performance
ALXO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$865.00 K
+$15.00 K+1.76%
September 30, 2024
Summary
- As of February 7, 2025, ALXO TTM depreciation & amortization is $865.00 thousand, with the most recent change of +$15.00 thousand (+1.76%) on September 30, 2024.
- Over the past year, ALXO TTM D&A has increased by +$131.00 thousand (+17.85%).
- ALXO TTM D&A is now at all-time high.
Performance
ALXO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ALXO Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +144.4% | +7.2% | +17.9% |
3 y3 years | +313.9% | +286.2% | +731.7% |
5 y5 years | +94.0% | +4380.0% | +820.2% |
ALXO Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +1539.2% | at high | +558.8% | at high | +1596.1% |
5 y | 5-year | at high | +1539.2% | at high | +4380.0% | at high | +4019.1% |
alltime | all time | at high | +1539.2% | at high | +4380.0% | at high | +4019.1% |
ALX Oncology Holdings Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $224.00 K(+1.8%) | $865.00 K(+1.8%) |
Jun 2024 | - | $220.00 K(+2.8%) | $850.00 K(+1.6%) |
Mar 2024 | - | $214.00 K(+3.4%) | $837.00 K(+0.1%) |
Dec 2023 | $836.00 K(+144.4%) | $207.00 K(-1.0%) | $836.00 K(+13.9%) |
Sep 2023 | - | $209.00 K(+1.0%) | $734.00 K(+18.4%) |
Jun 2023 | - | $207.00 K(-2.8%) | $620.00 K(+24.7%) |
Mar 2023 | - | $213.00 K(+102.9%) | $497.00 K(+45.3%) |
Dec 2022 | $342.00 K(+570.6%) | $105.00 K(+10.5%) | $342.00 K(+26.2%) |
Sep 2022 | - | $95.00 K(+13.1%) | $271.00 K(+48.9%) |
Jun 2022 | - | $84.00 K(+44.8%) | $182.00 K(+75.0%) |
Mar 2022 | - | $58.00 K(+70.6%) | $104.00 K(+103.9%) |
Dec 2021 | $51.00 K | $34.00 K(+466.7%) | $51.00 K(+131.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $6000.00(0.0%) | $22.00 K(+4.8%) |
Jun 2021 | - | $6000.00(+20.0%) | $21.00 K(-77.7%) |
Mar 2021 | - | $5000.00(0.0%) | $94.00 K(-53.5%) |
Dec 2020 | $202.00 K(-52.9%) | $5000.00(0.0%) | $202.00 K(-34.6%) |
Sep 2020 | - | $5000.00(-93.7%) | $309.00 K(-25.5%) |
Jun 2020 | - | $79.00 K(-30.1%) | $415.00 K(-6.7%) |
Mar 2020 | - | $113.00 K(+0.9%) | $445.00 K(+3.7%) |
Dec 2019 | $429.00 K(-0.5%) | $112.00 K(+0.9%) | $429.00 K(+35.3%) |
Sep 2019 | - | $111.00 K(+1.8%) | $317.00 K(+53.9%) |
Jun 2019 | - | $109.00 K(+12.4%) | $206.00 K(+112.4%) |
Mar 2019 | - | $97.00 K | $97.00 K |
Dec 2018 | $431.00 K | - | - |
FAQ
- What is ALX Oncology Holdings annual depreciation & amortization?
- What is the all time high annual D&A for ALX Oncology Holdings?
- What is ALX Oncology Holdings annual D&A year-on-year change?
- What is ALX Oncology Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly D&A year-on-year change?
- What is ALX Oncology Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for ALX Oncology Holdings?
- What is ALX Oncology Holdings TTM D&A year-on-year change?
What is ALX Oncology Holdings annual depreciation & amortization?
The current annual D&A of ALXO is $836.00 K
What is the all time high annual D&A for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual depreciation & amortization is $836.00 K
What is ALX Oncology Holdings annual D&A year-on-year change?
Over the past year, ALXO annual depreciation & amortization has changed by +$494.00 K (+144.44%)
What is ALX Oncology Holdings quarterly depreciation & amortization?
The current quarterly D&A of ALXO is $224.00 K
What is the all time high quarterly D&A for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly depreciation & amortization is $224.00 K
What is ALX Oncology Holdings quarterly D&A year-on-year change?
Over the past year, ALXO quarterly depreciation & amortization has changed by +$15.00 K (+7.18%)
What is ALX Oncology Holdings TTM depreciation & amortization?
The current TTM D&A of ALXO is $865.00 K
What is the all time high TTM D&A for ALX Oncology Holdings?
ALX Oncology Holdings all-time high TTM depreciation & amortization is $865.00 K
What is ALX Oncology Holdings TTM D&A year-on-year change?
Over the past year, ALXO TTM depreciation & amortization has changed by +$131.00 K (+17.85%)